Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2012

01.11.2012

Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients

verfasst von: Philip F. Binkley, James G. Porterfield, Linda M. Porterfield, Scott L. Beau, Raffaele Corbisiero, G. Stephen Greer, Charles J. Love, Melanie Turkel, Anders Bjorling, Fujian Qu, Taraneh G. Farazi

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pulmonary edema (PE) is associated with fluid accumulation in the lungs. Device-based impedance measurements have been used to detect fluid overload prior to hospitalization. However, studies have reported a high false positive rate (FPR). The objective of this study was to develop and test a new multivector impedance-based algorithm that reliably tracks PE clinical events.

Methods

We enrolled patients with implanted CRT-Ds in 23 US centers within 2 weeks of device implant. Six-vector impedance data was collected automatically by the CRT-Ds every 30 min during emergency department visits/hospitalizations and every 2 h at all other times. Detection algorithms for cardiac resynchronization therapy defibrillator (CRT-D) and implantable cardiac defibrillator (ICD) devices were developed using those impedance vectors that would be available in corresponding devices and retrospectively evaluated.

Results

There were 75 patients (69 % male), mean age 66 ± 12 years, with a LVEF of 23 ± 6 % and QRS of 149 ± 25 ms. Twenty-one major clinical events occurred over 8.2 ± 2.6 months of follow-up time. CRT-D vector combinations resulted in a sensitivity of 71.4 % (95 % confidence interval 47.8–88.7) and a FPR of 0.56 (0.30–0.94) false positives per patient-year (FPs/pt-yr); ICD vector combinations resulted in a sensitivity of 61.9 % (38.4–81.9) and a FPR of 0.63 (0.36–0.90) FPs/pt-yr. In comparison, the single-vector RVCoil-Can implementation of this algorithm resulted in a sensitivity of 57.1 % (34.0–78.2) and a FPR of 0.74 (0.44–1.12) FPs/pt-yr.

Conclusions

This multivector impedance algorithm was effective in tracking PE clinical events in this patient population. Additional studies are needed to prospectively evaluate the performance of this algorithm in a larger population.
Literatur
1.
Zurück zum Zitat Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De, S. G., et al. (2010). Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation, 121(7), e46–e215.PubMedCrossRef Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De, S. G., et al. (2010). Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation, 121(7), e46–e215.PubMedCrossRef
2.
Zurück zum Zitat Keenan, P. S., Normand, S. L., Lin, Z., Drye, E. E., Bhat, K. R., Ross, J. S., et al. (2008). An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circulation Cardiovascular Quality and Outcomes, 1(1), 29–37.PubMedCrossRef Keenan, P. S., Normand, S. L., Lin, Z., Drye, E. E., Bhat, K. R., Ross, J. S., et al. (2008). An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circulation Cardiovascular Quality and Outcomes, 1(1), 29–37.PubMedCrossRef
3.
Zurück zum Zitat Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009). Rehospitalizations among patients in the Medicare fee-for-service program. The New England Journal of Medicine, 360(14), 1418–1428.PubMedCrossRef Jencks, S. F., Williams, M. V., & Coleman, E. A. (2009). Rehospitalizations among patients in the Medicare fee-for-service program. The New England Journal of Medicine, 360(14), 1418–1428.PubMedCrossRef
4.
Zurück zum Zitat Ross, J. S., Chen, J., Lin, Z., Bueno, H., Curtis, J. P., Keenan, P. S., et al. (2010). Recent national trends in readmission rates after heart failure hospitalization. Circulation Heart Failure, 3(1), 97–103.PubMedCrossRef Ross, J. S., Chen, J., Lin, Z., Bueno, H., Curtis, J. P., Keenan, P. S., et al. (2010). Recent national trends in readmission rates after heart failure hospitalization. Circulation Heart Failure, 3(1), 97–103.PubMedCrossRef
5.
Zurück zum Zitat Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K., et al. (2002). Long-term trends in the incidence of and survival with heart failure. The New England Journal of Medicine, 347(18), 1397–1402.PubMedCrossRef Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K., et al. (2002). Long-term trends in the incidence of and survival with heart failure. The New England Journal of Medicine, 347(18), 1397–1402.PubMedCrossRef
6.
Zurück zum Zitat Yu, C. M., Wang, L., Chau, E., Chan, R. H., Kong, S. L., Tang, M. O., et al. (2005). Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation, 112(6), 841–848.PubMedCrossRef Yu, C. M., Wang, L., Chau, E., Chan, R. H., Kong, S. L., Tang, M. O., et al. (2005). Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation, 112(6), 841–848.PubMedCrossRef
7.
Zurück zum Zitat Bourge, R. C., Abraham, W. T., Adamson, P. B., Aaron, M. F., Aranda, J. M., Jr., Magalski, A., et al. (2008). Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. Journal of the American College of Cardiology, 51(11), 1073–1079.PubMedCrossRef Bourge, R. C., Abraham, W. T., Adamson, P. B., Aaron, M. F., Aranda, J. M., Jr., Magalski, A., et al. (2008). Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. Journal of the American College of Cardiology, 51(11), 1073–1079.PubMedCrossRef
8.
Zurück zum Zitat Ritzema, J., Troughton, R., Melton, I., Crozier, I., Doughty, R., Krum, H., et al. (2010). Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation, 121(9), 1086–1095.PubMedCrossRef Ritzema, J., Troughton, R., Melton, I., Crozier, I., Doughty, R., Krum, H., et al. (2010). Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation, 121(9), 1086–1095.PubMedCrossRef
9.
Zurück zum Zitat Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., et al. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet, 377(9766), 658–666.PubMedCrossRef Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., et al. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet, 377(9766), 658–666.PubMedCrossRef
10.
Zurück zum Zitat Wang, L., Lahtinen, S., Lentz, L., Rakow, N., Kaszas, C., Ruetz, L., et al. (2005). Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing and Clinical Electrophysiology, 28(5), 404–411.PubMedCrossRef Wang, L., Lahtinen, S., Lentz, L., Rakow, N., Kaszas, C., Ruetz, L., et al. (2005). Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing and Clinical Electrophysiology, 28(5), 404–411.PubMedCrossRef
11.
Zurück zum Zitat Khoury, D. S., Naware, M., Siou, J., Blomqvist, A., Mathuria, N. S., Wang, J., et al. (2009). Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. Journal of the American College of Cardiology, 53(12), 1075–1081.PubMedCrossRef Khoury, D. S., Naware, M., Siou, J., Blomqvist, A., Mathuria, N. S., Wang, J., et al. (2009). Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. Journal of the American College of Cardiology, 53(12), 1075–1081.PubMedCrossRef
12.
Zurück zum Zitat Conraads, V. M., Tavazzi, L., Santini, M., Oliva, F., Gerritse, B., Yu, C. M., et al. (2011). Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. European Heart Journal, 32(18), 2266–2273.PubMedCrossRef Conraads, V. M., Tavazzi, L., Santini, M., Oliva, F., Gerritse, B., Yu, C. M., et al. (2011). Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. European Heart Journal, 32(18), 2266–2273.PubMedCrossRef
13.
Zurück zum Zitat Abraham, W. T., Compton, S., Haas, G., Foreman, B., Canby, R. C., Fishel, R., et al. (2011). Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the fluid accumulation status trial (FAST). Congestive Heart Failure, 17(2), 51–55.PubMedCrossRef Abraham, W. T., Compton, S., Haas, G., Foreman, B., Canby, R. C., Fishel, R., et al. (2011). Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the fluid accumulation status trial (FAST). Congestive Heart Failure, 17(2), 51–55.PubMedCrossRef
14.
Zurück zum Zitat Vollmann, D., Nagele, H., Schauerte, P., Wiegand, U., Butter, C., Zanotto, G., et al. (2007). Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal, 28(15), 1835–1840.PubMedCrossRef Vollmann, D., Nagele, H., Schauerte, P., Wiegand, U., Butter, C., Zanotto, G., et al. (2007). Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal, 28(15), 1835–1840.PubMedCrossRef
15.
Zurück zum Zitat Ypenburg, C., Bax, J. J., van der Wall, E. E., Schalij, M. J., & van Erven, L. (2007). Intrathoracic impedance monitoring to predict decompensated heart failure. The American Journal of Cardiology, 99(4), 554–557.PubMedCrossRef Ypenburg, C., Bax, J. J., van der Wall, E. E., Schalij, M. J., & van Erven, L. (2007). Intrathoracic impedance monitoring to predict decompensated heart failure. The American Journal of Cardiology, 99(4), 554–557.PubMedCrossRef
16.
Zurück zum Zitat Catanzariti, D., Lunati, M., Landolina, M., Zanotto, G., Lonardi, G., Iacopino, S., et al. (2009). Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing and Clinical Electrophysiology, 32(3), 363–370.PubMedCrossRef Catanzariti, D., Lunati, M., Landolina, M., Zanotto, G., Lonardi, G., Iacopino, S., et al. (2009). Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing and Clinical Electrophysiology, 32(3), 363–370.PubMedCrossRef
17.
Zurück zum Zitat Wang, L. (2007). Fundamentals of intrathoracic impedance monitoring in heart failure. The American Journal of Cardiology, 99(10A), 3G–10G.PubMedCrossRef Wang, L. (2007). Fundamentals of intrathoracic impedance monitoring in heart failure. The American Journal of Cardiology, 99(10A), 3G–10G.PubMedCrossRef
18.
Zurück zum Zitat Kramer, D. B., & Maisel, W. H. (2010). An unusual cause of abnormal intrathoracic impedance in a patient with arrhythmogenic right ventricular cardiomyopathy. Pacing and Clinical Electrophysiology, 34(7), e60–3.PubMedCrossRef Kramer, D. B., & Maisel, W. H. (2010). An unusual cause of abnormal intrathoracic impedance in a patient with arrhythmogenic right ventricular cardiomyopathy. Pacing and Clinical Electrophysiology, 34(7), e60–3.PubMedCrossRef
19.
Zurück zum Zitat Ware, L. B., & Matthay, M. A. (2005). Clinical practice. Acute pulmonary edema. The New England Journal of Medicine, 353(26), 2788–2796.PubMedCrossRef Ware, L. B., & Matthay, M. A. (2005). Clinical practice. Acute pulmonary edema. The New England Journal of Medicine, 353(26), 2788–2796.PubMedCrossRef
Metadaten
Titel
Feasibility of using multivector impedance to monitor pulmonary congestion in heart failure patients
verfasst von
Philip F. Binkley
James G. Porterfield
Linda M. Porterfield
Scott L. Beau
Raffaele Corbisiero
G. Stephen Greer
Charles J. Love
Melanie Turkel
Anders Bjorling
Fujian Qu
Taraneh G. Farazi
Publikationsdatum
01.11.2012
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2012
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-012-9693-2

Weitere Artikel der Ausgabe 2/2012

Journal of Interventional Cardiac Electrophysiology 2/2012 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.